NT-proBNP and circulating inflammation markers in prediction of a normal myocardial scintigraphy in patients with symptoms of coronary artery disease.

by Camilla Noelle Rathcke, Erik Kjøller, Niels Fogh-Andersen, Bo Zerahn, Henrik Vestergaard
Published 2010-12-01

Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial

by Martin Schultz, Line J. H. Rasmussen, Thomas Kallemose, Erik Kjøller, Morten N. Lind, Lisbet Ravn, Theis Lange, Lars Køber, Lars S. Rasmussen, Jesper Eugen-Olsen, Kasper Iversen
Published 2019-04-01

Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial

by Per Winkel, Jørgen Hilden, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud, Kasper Karmark Iversen, Gorm Boje Jensen, Mette Bjerre
Published 2020-08-01

Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patien...

by Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Theis Lange, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud
Published 2017-03-01

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease

by Jakob Schroder, Janus Christian Jakobsen, Per Winkel, Jørgen Hilden, Gorm Boje Jensen, Ahmad Sajadieh, Anders Larsson, Johan Ärnlöv, Marina Harutyunyan, Julia S. Johansen, Erik Kjøller, Christian Gluud, Jens Kastrup
Published 2020-03-01

10‐Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin...

by Axel C. Carlsson, Toralph Ruge, Erik Kjøller, Jørgen Hilden, Hans Jørn Kolmos, Ahmad Sajadieh, Jens Kastrup, Gorm Boje Jensen, Anders Larsson, Christoph Nowak, Janus Christian Jakobsen, Per Winkel, Christian Gluud, Johan Ärnlöv
Published 2018-05-01

Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study

by Erik Nilsson, Jens Kastrup, Ahmad Sajadieh, Gorm Boje Jensen, Erik Kjøller, Hans Jørn Kolmos, Jonas Wuopio, Christoph Nowak, Anders Larsson, Janus Christian Jakobsen, Per Winkel, Christian Gluud, Kasper K Iversen, Johan Ärnlöv, Axel C. Carlsson
Published 2020-01-01

Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)

by Martin Schultz, Line Jee Hartmann Rasmussen, Malene H. Andersen, Jakob S. Stefansson, Alexander C. Falkentoft, Morten Alstrup, Andreas Sandø, Sarah L. K. Holle, Jeppe Meyer, Peter B. S. Törnkvist, Thomas Høi-Hansen, Erik Kjøller, Birgitte Nybo Jensen, Morten Lind, Lisbet Ravn, Thomas Kallemose, Theis Lange, Lars Køber, Lars Simon Rasmussen, Jesper Eugen-Olsen, Kasper Karmark Iversen
Published 2018-08-01